These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 36564106)

  • 1. Evaluating the feasibility and acceptability of a safety protocol to mitigate SARS-CoV-2 transmission risks when participating in full-capacity live mass events: a cross-sectional survey and interview-based study.
    Dallera G; Alaa A; El-Osta A; Kreindler J; Harris M
    BMJ Open; 2022 Dec; 12(12):e063838. PubMed ID: 36564106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 risk mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region.
    Burnside G; Cheyne CP; Leeming G; Humann M; Darby A; Green MA; Crozier A; Maskell S; O'Halloran K; Musi E; Carmi E; Khan N; Fisher D; Corcoran R; Dunning J; Edmunds WJ; Tharmaratnam K; Hughes DM; Malki-Epshtein L; Cook M; Roberts BM; Gallagher E; Howell K; Chand M; Kemp R; Boulter M; Fowler T; Semple MG; Coffey E; Ashton M; ; García-Fiñana M; Buchan IE
    J R Soc Med; 2024 Jan; 117(1):11-23. PubMed ID: 37351911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance.
    Atchison C; Pristerà P; Cooper E; Papageorgiou V; Redd R; Piggin M; Flower B; Fontana G; Satkunarajah S; Ashrafian H; Lawrence-Jones A; Naar L; Chigwende J; Gibbard S; Riley S; Darzi A; Elliott P; Ashby D; Barclay W; Cooke GS; Ward H
    Clin Infect Dis; 2021 May; 72(9):e384-e393. PubMed ID: 32785665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach.
    Green K; Micocci M; Hicks T; Winter A; Martin JE; Shinkins B; Shaw L; Price C; Davies K; Allen JA
    BMJ Open; 2022 Nov; 12(11):e064038. PubMed ID: 36328389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Values and Preferences Toward SARS-CoV-2 Self-testing Among the General Population and Their Representatives, Health Care Personnel, and Decision-Makers: Protocol for a Multicountry Mixed Methods Study.
    Shilton S; Ivanova Reipold E; Roca Álvarez A; Martínez-Pérez GZ
    JMIR Res Protoc; 2021 Nov; 10(11):e33088. PubMed ID: 34726608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.
    Wienkes H; Vilen K; Lorentz A; Gerlach D; Wang X; Saupe A; Danila R; Lynfield R; Smith K; Medus C
    JAMA Netw Open; 2022 Feb; 5(2):e220536. PubMed ID: 35212747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
    Martin AF; Denford S; Love N; Ready D; Oliver I; Amlôt R; Rubin GJ; Yardley L
    BMC Public Health; 2021 Jun; 21(1):1067. PubMed ID: 34090404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a population data science approach to assess increased risk of COVID-19 associated with attending large events.
    Drakesmith M; Hobson G; John G; Stegall E; Gould A; Parkinson J; Thomas DR
    Int J Popul Data Sci; 2021; 6(3):1711. PubMed ID: 35784494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.
    Martínez-Pérez GZ; Shilton S; Saruê M; Cesario H; Banerji A; Batheja D; Cunha JP; Baptista R; Schirmer J; Ivanova Reipold E; Machado Dias A
    BMC Infect Dis; 2022 Sep; 22(1):720. PubMed ID: 36056299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities and Temporal Trends in COVID-19 Exposures and Mitigating Behaviors Among Black and Hispanic Adults in an Urban Setting.
    Badri S; Sardá V; Moncada JS; Merçon M; Rezai K; Weinstein RA; Trick WE
    JAMA Netw Open; 2021 Sep; 4(9):e2125187. PubMed ID: 34581798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.